Gossamer Bio, Inc. (GOSS)

2.70 -0.17 (-5.92%) USD  |  NASDAQ  |  Jan 23, 16:00
2.75 +0.05 (+1.85%) Pre-Market: 20:00
More

Gossamer Bio Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Madrigal Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Rezolute, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade